Tuesday, October 7, 2025
LinkedPrime

Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers - CNBC

Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar deals that would make them immune to tariffs.

Annika Kim Constantino •
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers - CNBC

President Donald Trump's long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer. Trump's … [+4441 chars]

Read original article →